Resmed
ResMed Inc., a leading player in the digital health and sleep solutions industry, is headquartered in San Diego, California, with significant operations across North America, Europe, and Asia-Pacific. Founded in 1989, ResMed has consistently innovated in the fields of sleep apnoea, chronic obstructive pulmonary disease (COPD), and cloud-connected devices, marking key milestones such as the introduction of the first portable CPAP device. The company’s core offerings include advanced CPAP machines, cloud-based patient management software, and a range of masks and accessories designed for comfort and efficacy. ResMed's commitment to integrating technology with healthcare has positioned it as a market leader, recognised for its pioneering efforts in telehealth and remote patient monitoring. With a strong focus on improving patient outcomes, ResMed continues to set industry standards and drive advancements in respiratory care.
DitchCarbon Score
How does Resmed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Resmed's score of 42 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Resmed's reported carbon emissions
As of 2023, ResMed reported total carbon emissions of approximately 28.4 million tonnes CO2e, with emissions from Scope 1 at about 4.5 million tonnes CO2e and Scope 2 at approximately 23.9 million tonnes CO2e. This represents a slight decrease from 2022, where total emissions were around 28.7 million tonnes CO2e. ResMed has committed to achieving net-zero emissions across all scopes by 2050, with interim targets aligned with the Science Based Targets initiative (SBTi). The company has set a long-term goal to reduce greenhouse gas emissions from its operations, which includes both Scope 1 and Scope 2 emissions. In recent years, ResMed has demonstrated a commitment to sustainability, with emissions intensity (Scope 1 and 2) decreasing to about 6.7 kg CO2e per million dollars of revenue in 2023, down from 6.1 kg CO2e in 2022. This trend reflects the company's ongoing efforts to enhance energy efficiency and reduce its carbon footprint in the healthcare equipment sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Resmed is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
